Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,360.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 4,100.00
  • 52 Week Low: 2,950.00
  • Currency: UK Pounds
  • Shares Issued: 5.14m
  • Volume: 478
  • Market Cap: £172.79m
  • Beta: 0.18

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
18.46% below the market average18.46% below the market average18.46% below the market average18.46% below the market average18.46% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
1yr Revenue Growth
33.50% above the market average33.50% above the market average33.50% above the market average33.50% above the market average33.50% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
40.21% below the market average40.21% below the market average40.21% below the market average40.21% below the market average40.21% below the market average
Sector averageSector averageSector averageSector averageSector average
1yr DPS Growth
59.85% above the market average59.85% above the market average59.85% above the market average59.85% above the market average59.85% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
49.72% above the market average49.72% above the market average49.72% above the market average49.72% above the market average49.72% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Price Book Ratio
95.72% below the market average95.72% below the market average95.72% below the market average95.72% below the market average95.72% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average
25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average
Price Chg 3m
56.58% below the market average56.58% below the market average56.58% below the market average56.58% below the market average56.58% below the market average
22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
37.45% above the market average37.45% above the market average37.45% above the market average37.45% above the market average37.45% above the market average
50.88% above the sector average50.88% above the sector average50.88% above the sector average50.88% above the sector average50.88% above the sector average
Momentum 20
96.10% above the market average96.10% above the market average96.10% above the market average96.10% above the market average96.10% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
68.87% above the market average68.87% above the market average68.87% above the market average68.87% above the market average68.87% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
ROCE
75.20% above the market average75.20% above the market average75.20% above the market average75.20% above the market average75.20% above the market average
36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
89.95% above the market average89.95% above the market average89.95% above the market average89.95% above the market average89.95% above the market average
89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average
Forecast EPS
83.66% above the market average83.66% above the market average83.66% above the market average83.66% above the market average83.66% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
34.8% below the market average34.8% below the market average34.8% below the market average34.8% below the market average34.8% below the market average
10% below the sector average10% below the sector average10% below the sector average10% below the sector average10% below the sector average
Operating Profit Loss
18.76% above the market average18.76% above the market average18.76% above the market average18.76% above the market average18.76% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
27.85% below the market average27.85% below the market average27.85% below the market average27.85% below the market average27.85% below the market average
5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average
Cash
8.2% below the market average8.2% below the market average8.2% below the market average8.2% below the market average8.2% below the market average
8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
47.29% below the market average47.29% below the market average47.29% below the market average47.29% below the market average47.29% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,360.00p
Change Today -30.00p
% Change -0.89 %
52 Week High 4,100.00
52 Week Low 2,950.00
Volume 478
Shares Issued 5.14m
Market Cap £172.79m
Beta 0.18

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.31% below the market average96.31% below the market average96.31% below the market average96.31% below the market average96.31% below the market average
89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average
Price Trend
26.80% above the market average26.80% above the market average26.80% above the market average26.80% above the market average26.80% above the market average
35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average
Income
41.72% below the market average41.72% below the market average41.72% below the market average41.72% below the market average41.72% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Growth
6.39% above the market average6.39% above the market average6.39% above the market average6.39% above the market average6.39% above the market average
31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average

Bioventix Dividends

  Latest Previous
  Final Special
Ex-Div 31-Oct-19 31-Oct-19
Paid 15-Nov-19 15-Nov-19
Amount 43.00p 47.00p

Trades for 06-Dec-2019

Time Volume / Share Price
13:43 125 @ 3,320.00p
13:33 151 @ 3,320.00p
11:36 115 @ 3,320.00p
10:57 38 @ 3,350.00p
09:21 49 @ 3,350.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page